Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Intermuscular coherence as a candidate biomarker for primary lateral sclerosis.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: July 13, 2026
Optimizing Research Operations and Resource Utilization in ALS Care: Insights From the Tofersen Antisense Oligonucleotide Expanded Access Protocol.
Journal: Muscle & nerve
Published: February 12, 2026
Network analysis of the cerebrospinal fluid proteome reveals shared and unique differences between sporadic and familial forms of amyotrophic lateral sclerosis.
Journal: Molecular neurodegeneration
Published: February 27, 2025
Intermuscular coherence from muscle pairs in the leg as a biomarker for amyotrophic lateral sclerosis.
Journal: Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
Published: January 20, 2025
Clinician Perspectives Highlight the Need for Early Dyadic Coping Skills for People Living With Amyotrophic Lateral Sclerosis.
Journal: Journal of pain and symptom management
Published: September 08, 2024
Body mass index is lower in asymptomatic C9orf72 expansion carriers but not in SOD1 pathogenic variant carriers compared to gene negatives.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: August 28, 2024
Intermuscular coherence as an early biomarker for amyotrophic lateral sclerosis: The protocol for a prospective, multicenter study.
Journal: PloS one
Published: April 12, 2024
Access for ALL in ALS: A large-scale, inclusive, collaborative consortium to unlock the molecular and genetic mechanisms of amyotrophic lateral sclerosis.
Journal: Muscle & nerve
Published: February 22, 2024
A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS-FTD.
Journal: Nature medicine
Published: January 24, 2023
Showing 1-11 of 11
Last Updated: 09/26/2026